Pharmaceutical companies exploring new medications can come to Maine if they want to fail – and not just fail, but fail fast.

That’s the sales pitch of MDI Bioscience, and it only sounds odd if you forget about all the dead ends that researchers go down before they can bring a new medicine to patients. Read more